electroCore, Inc. (NASDAQ:ECOR) Short Interest Update

electroCore, Inc. (NASDAQ:ECOR) saw a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 89,500 shares, a decrease of 22.8% from the December 31st total of 115,900 shares. Approximately 1.7% of the shares of the company are sold short. Based on an average daily volume of 124,900 shares, the days-to-cover ratio is currently 0.7 days.

Analysts Set New Price Targets

Separately, HC Wainwright lifted their price objective on shares of electroCore from $22.00 to $25.00 and gave the stock a “buy” rating in a research note on Wednesday, December 18th.

electroCore Stock Performance

Shares of electroCore stock traded up $1.01 on Friday, reaching $16.72. 90,335 shares of the stock were exchanged, compared to its average volume of 91,298. The firm has a market cap of $111.36 million, a PE ratio of -9.14 and a beta of 0.50. The firm’s 50 day moving average is $14.99 and its 200-day moving average is $10.28. electroCore has a one year low of $5.32 and a one year high of $18.67.

Institutional Investors Weigh In On electroCore

Large investors have recently modified their holdings of the business. International Assets Investment Management LLC boosted its position in electroCore by 689.1% in the third quarter. International Assets Investment Management LLC now owns 535,146 shares of the company’s stock valued at $3,864,000 after buying an additional 467,326 shares in the last quarter. HighTower Advisors LLC acquired a new stake in shares of electroCore during the 3rd quarter valued at $255,000. Geode Capital Management LLC boosted its holdings in shares of electroCore by 10.3% during the 3rd quarter. Geode Capital Management LLC now owns 63,485 shares of the company’s stock valued at $458,000 after acquiring an additional 5,951 shares in the last quarter. Finally, Renaissance Technologies LLC grew its position in electroCore by 3.4% during the 2nd quarter. Renaissance Technologies LLC now owns 68,786 shares of the company’s stock worth $442,000 after acquiring an additional 2,270 shares during the last quarter. Institutional investors and hedge funds own 26.74% of the company’s stock.

About electroCore

electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.